ENZO BIOCHEM, INC. Weighted Average Number Basic Shares Outstanding Adjustment, Pro Forma
ENZO BIOCHEM, INC. reported Weighted Average Number Basic Shares Outstanding Adjustment, Pro Forma of 4.10 million shares for the 3-month period ending 2023-04-30, per its 10-Q filed 2023-06-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma · last filed 2023-06-14
- ENZO BIOCHEM, INC. weighted average number basic shares outstanding adjustment, pro forma for the quarter ending 2023-04-30 was 4.10M shares, a 210.61% increase year-over-year.
- ENZO BIOCHEM, INC. weighted average number basic shares outstanding adjustment, pro forma for the quarter ending 2023-01-31 was 4.19M shares, a 283.96% increase year-over-year.
- ENZO BIOCHEM, INC. weighted average number basic shares outstanding adjustment, pro forma for the quarter ending 2022-04-30 was 1.32M shares.
- ENZO BIOCHEM, INC. weighted average number basic shares outstanding adjustment, pro forma for the quarter ending 2022-01-31 was 1.09M shares.
| Period end | Weighted Average Number Basic Shares Outstanding Adjustment, Pro Forma 3 month | Weighted Average Number Basic Shares Outstanding Adjustment, Pro Forma 6 month | Weighted Average Number Basic Shares Outstanding Adjustment, Pro Forma 9 month |
|---|---|---|---|
| 2023-04-30 | 4.10M shares 10-Q · filed 2023-06-14 | 4.14M shares derived: average of 2 quarters · filed 2023-06-14 | 3.63M shares 10-Q · filed 2023-06-14 |
| 2023-01-31 | 4.19M shares 10-Q · filed 2023-03-20 | 3.39M shares 10-Q · filed 2023-03-20 | |
| 2022-04-30 | 1.32M shares 10-Q · filed 2023-06-14 | 1.21M shares derived: average of 2 quarters · filed 2023-06-14 | 1.07M shares 10-Q · filed 2023-06-14 |
| 2022-01-31 | 1.09M shares 10-Q · filed 2023-03-20 | 942.00K shares 10-Q · filed 2023-03-20 |